How many times We miss out on a NEW drug approval spike???
Apr 12, 2016 19:50:00 GMT
stcks, miamianne67, and 8 more like this
Post by Deleted on Apr 12, 2016 19:50:00 GMT
The following link lists most but not all pudfa dates, fda hearings, phase data read out dates, etc.
www.biopharmcatalyst.com/fda-calendar/
If I were playing this as a game, and the goal was to accumulate points, umm $, I would study the PUDFA dates, and hearings. I would check out each stock, and buy on BIG market pullbacks roughly 12 weeks ahead of the EVENT date. I would exit 2/3 or 3/4 prior to the date regardless if I thought approval was a given, umm, see Rayaldee. I would leave a ton of money on the table with this approach, but not all. If a drug FAILS, I made the run up money, and saved a ton on the spike down, but not all. My return might be lower than those holding all, but my game plan is to not be arrogant, take same, protect it, play again.
Had a phase 3 meeting today for a blood thinner, a study I hope to enter if the medicals check out. Well, always the researcher, looking for ideas, I had to ask a bunch of questions. There is no approved rescue medication for the drug in this study to date. HOWEVER, PTLA has a drug with the fda pdufa Aug 17. This study I am hoping to be in is sponsored by Bayer. So not wasting a trip to the hospital for tests, I discovered PTLA. Since then I discovered Bayer has partnered with PTLA to distribute the antidote to their blood thinning drug in Japan. Now, the Bayer Drug is on the market for several indications already, but not stroke It is on the market DANGEROUSLY because there is no antidote, so the plta drug has a market created by PFE and BMY and a few others who market BLOOD thinners. Ever SEE pradaxa advertised on TV, umm, I have. It is a blood thinner with no antidote, and they paid about 450M in a class action for the 100 or so patients who bled to death.
So the PLTA drug will not cure cancer or anything, but it has a build in BIG market as the only rescue med for a whole class of blood thinners.
PTLA isa trade idea, I own none, but might in the next8 weeks, or around 12 weeks prior to Aug. 17
www.biopharmcatalyst.com/fda-calendar/
If I were playing this as a game, and the goal was to accumulate points, umm $, I would study the PUDFA dates, and hearings. I would check out each stock, and buy on BIG market pullbacks roughly 12 weeks ahead of the EVENT date. I would exit 2/3 or 3/4 prior to the date regardless if I thought approval was a given, umm, see Rayaldee. I would leave a ton of money on the table with this approach, but not all. If a drug FAILS, I made the run up money, and saved a ton on the spike down, but not all. My return might be lower than those holding all, but my game plan is to not be arrogant, take same, protect it, play again.
Had a phase 3 meeting today for a blood thinner, a study I hope to enter if the medicals check out. Well, always the researcher, looking for ideas, I had to ask a bunch of questions. There is no approved rescue medication for the drug in this study to date. HOWEVER, PTLA has a drug with the fda pdufa Aug 17. This study I am hoping to be in is sponsored by Bayer. So not wasting a trip to the hospital for tests, I discovered PTLA. Since then I discovered Bayer has partnered with PTLA to distribute the antidote to their blood thinning drug in Japan. Now, the Bayer Drug is on the market for several indications already, but not stroke It is on the market DANGEROUSLY because there is no antidote, so the plta drug has a market created by PFE and BMY and a few others who market BLOOD thinners. Ever SEE pradaxa advertised on TV, umm, I have. It is a blood thinner with no antidote, and they paid about 450M in a class action for the 100 or so patients who bled to death.
So the PLTA drug will not cure cancer or anything, but it has a build in BIG market as the only rescue med for a whole class of blood thinners.
PTLA isa trade idea, I own none, but might in the next8 weeks, or around 12 weeks prior to Aug. 17